1,7250
18-февраля-25 09:57:05
15 мин. задержка
Акции
-0,0150
-0,86%
Сегодняшний диапазон
1,7150 - 1,7646
ISIN
N/A
Источник
NASDAQ
Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development
10 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire
Neumora Therapeutics Announces Pricing of Initial Public Offering
14 сен 2023 20:49:04 Источник Nasdaq GlobeNewswire